title: Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor.
abstract: We demonstrated previously that heparin-derived hexasaccharides are the smallest fragments of the polysaccharide with comparable basic fibroblast growth factor (bFGF)-modulating activity in vitro (Ishihara, M., Tyrrell, D.J., Stauber, G.B., Brown, S., Cousens, L., and Stack, R.J. (1993) J. Biol. Chem. 268, 4675-4683. In this report, a specific hexasaccharide having high affinity for recombinant human bFGF was isolated and its structure deduced by analysis of its reduced disaccharide products after treatment with nitrous acid at pH 1.5, and by 1H NMR spectroscopy. The hexasaccharide has the structure [IdoA(2-OSO3)alpha 1-4GlcNSO3(6-OSO3)alpha 1-4]2IdoA(2-OSO3)alpha 1-4 AManR(6-OSO3). The hexasaccharide effectively inhibits the binding of syndecan-transfected RO-12 UC cells to bFGF-coated wells (Ishihara, M., Tyrrell, D.J., Kiefer, M.C., Barr, P.J., and Swiedler, S.J. (1992) Anal. Biochem. 202, 310-315), prevents the binding of 125I-bFGF to confluent monolayers of adrenocortical endothelial (ACE) cells, and inhibits the bFGF-dependent proliferation of ACE cells. Unlike the heparin from which it was derived, however, the hexasaccharide cannot promote the binding of 125I-bFGF to a recombinant high affinity bFGF receptor (flg) or restore the bFGF-dependent proliferative response to ACE cells grown in the presence of 5 mM sodium chlorate. Collectively, these data indicate that a hexasaccharide can be as effective as heparin as an antagonist of bFGF-mediated cell mitogenesis.
authors.affiliation: Glycomed Incorporated, Alameda, California 94501.
authors.forename: D J
authors.initials: DJ
authors.lastname: Tyrrell
authors.forename: M
authors.initials: M
authors.lastname: Ishihara
authors.forename: N
authors.initials: N
authors.lastname: Rao
authors.forename: A
authors.initials: A
authors.lastname: Horne
authors.forename: M C
authors.initials: MC
authors.lastname: Kiefer
authors.forename: G B
authors.initials: GB
authors.lastname: Stauber
authors.forename: L H
authors.initials: LH
authors.lastname: Lam
authors.forename: R J
authors.initials: RJ
authors.lastname: Stack
mesh_terms: D000818:Animals; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D000091344:Filaggrin Proteins; D006493:Heparin / Q000737:chemistry*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D009844:Oligosaccharides / Q000737:chemistry* / Q000378:metabolism; D013379:Substrate Specificity; D013552:Swine
chemical_list: C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D009844:Oligosaccharides; D016222:Fibroblast Growth Factor 2; D006493:Heparin